FLUCONAZOLE TABLETS

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) for 4,000 bottles of FLUCONAZOLE TABLETS with National Drug Code 51407-0425-30, at a unit price of $54.85, totaling $219.40. The award was issued on July 20, 2026, under solicitation SPE2DP26F7805, with delivery required by August 4, 2026, to Fort Bragg, North Carolina. The contract follows commercial item acquisition procedures under FAR Part 12, incorporating standard clauses such as 52.212-4 and 52.212-5 for inspection and acceptance, with final inspection and acceptance occurring at the destination. The item must be shipped via traceable means, prohibited from parcel post, and marked with the MARKFOR designation including the item number, purchase request, line item, manufacturer CAGE code (1HT23), and NDC. Payment will be processed through the Defense Finance and Accounting Service in Columbus, Ohio, using accounting code 97X4930 5CBX 001 2620 S33189, with invoices required to comply with DFARS 252.232-7003. The acquisition is set aside for small businesses under NAICS code 325412, with a size standard of 1,300 employees, and the order is rated under the Defense Priorities and Allocation System (DPAS), requiring compliance with 15 CFR 700. Contract administration is managed by the DLA Medical Supply Chain, with contracting officer Lorinda Ferraiolo and administrative contacts for medical supply chain operations. The offeror’s CAGE code is 1UNB0, while the manufacturer is identified under CAGE 1HT23. No specific packaging, preservation, or bar-coding standards from MIL-STD are cited, and while attachment ATTACH_9900_New_DVD is referenced, no detailed specification or quality standards beyond conformance to the contract are provided. The contract does not include options, performance periods beyond delivery date, or explicitly designated COR/COTR roles.